Home/Filings/4/0002001011-25-000113
4//SEC Filing

KOZARICH JOHN W 4

Accession 0002001011-25-000113

CIK 0000886163other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 5:08 PM ET

Size

16.7 KB

Accession

0002001011-25-000113

Insider Transaction Report

Form 4
Period: 2025-12-01
Transactions
  • Sale

    Common Stock

    2025-12-01$193.86/sh92$17,83544,496 total
  • Sale

    Common Stock

    2025-12-01$194.76/sh179$34,86244,317 total
  • Sale

    Common Stock

    2025-12-01$195.80/sh47$9,20344,270 total
  • Sale

    Common Stock

    2025-12-01$196.34/sh4$78544,266 total
  • Sale

    Common Stock

    2025-12-01$199.22/sh23$4,58244,151 total
  • Sale

    Common Stock

    2025-12-01$200.02/sh30$6,00044,121 total
Footnotes (8)
  • [F1]The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.
  • [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $193.2800 to $194.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $194.2800 to $195.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $195.2800 to $196.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $196.2800 to $197.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F6]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $197.2800 to $198.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F7]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $198.2800 to $199.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F8]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $199.2800 to $200.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeother

Related Parties

1
  • filerCIK 0001223000

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:08 PM ET
Size
16.7 KB